Breakdown | ||||
Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
24.19M | 18.60M | 18.47M | 19.21M | 14.06M | Gross Profit |
-2.05M | -2.40M | 1.01M | 1.86M | 650.64K | EBIT |
-43.96M | -34.07M | -18.97M | -15.74M | -12.82M | EBITDA |
-18.69M | -25.03M | -12.69M | -11.19M | -9.32M | Net Income Common Stockholders |
-25.26M | -23.19M | -16.34M | -9.11M | -7.08M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
42.96M | 74.47M | 24.98M | 15.13M | 11.08M | Total Assets |
112.40M | 127.51M | 61.21M | 51.62M | 42.76M | Total Debt |
3.26M | 1.32M | 1.47M | 1.29M | 684.20K | Net Debt |
-39.70M | -73.15M | -23.51M | -13.84M | -10.40M | Total Liabilities |
28.39M | 22.55M | 16.41M | 13.48M | 16.53M | Stockholders Equity |
83.79M | 103.73M | 43.49M | 38.15M | 26.23M |
Cash Flow | Free Cash Flow | |||
-33.13M | -30.29M | -12.76M | -15.06M | 3.68M | Operating Cash Flow |
-13.68M | -17.26M | -3.74M | -8.12M | 10.25M | Investing Cash Flow |
-17.55M | -13.03M | 13.83M | -6.94M | -16.19M | Financing Cash Flow |
-280.00K | 79.77M | -232.33K | 19.11M | 12.60M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
69 Neutral | $2.23B | 11.88 | 4.78% | 6.00% | -13.90% | 0.56% | |
58 Neutral | AU$561.73M | 89.15 | 11.59% | ― | 9.76% | -28.92% | |
56 Neutral | AU$2.61B | 28.34 | 2.70% | 4.47% | 6.43% | ― | |
49 Neutral | $1.92B | -1.52 | -22.04% | 3.84% | 0.67% | -27.41% | |
48 Neutral | AU$70.83M | ― | -26.71% | ― | 15.24% | 8.35% | |
46 Neutral | $56.42M | ― | -19.25% | ― | ― | 65.04% | |
40 Underperform | AU$52.58M | ― | -16.88% | ― | -67.72% | 65.78% |
Calix Limited announced that its water treatment products sold in the U.S. are exempt from the tariffs imposed by the Trump administration, due to compliance with the United States-Mexico-Canada Agreement (USMCA). This exemption is significant for Calix as its Magnesia business, which heavily relies on U.S. sales, constitutes a major portion of the company’s revenue. The exemption positions Calix favorably in the U.S. market, especially given the country’s reliance on magnesia imports, predominantly from China, which are subject to tariffs.
Calix Limited has released its latest newsletter, providing updates on its major projects and the publication of its first half 2025 results. The company is leveraging its core platform technology and global partnerships to develop multiple environmental businesses aimed at delivering a positive global impact, aligning with global commitments to net-zero emissions.
Calix Limited, a company listed on the ASX, has announced a change in the interests of its substantial holder, TIGA Trading Pty Ltd. The notice indicates an increase in the voting power of TIGA Trading Pty Ltd from 8.67% to 10.81%, reflecting a significant acquisition of shares. This change in substantial holding could impact Calix’s market dynamics and stakeholder interests, potentially influencing its strategic decisions and shareholder value.
Calix Limited, a company listed on the ASX, has announced a change in the interests of its substantial holder, Thorney Technologies Ltd. The notice indicates an increase in Thorney Technologies Ltd’s voting power from 8.67% to 10.81%, reflecting a significant acquisition of shares. This change in substantial holding could impact Calix Limited’s shareholder dynamics and influence future company decisions.
Calix Ltd. has released its interim financial results for the first half of the fiscal year 2025, ending December 31, 2024. The presentation emphasizes that the information provided is for general purposes and not intended as financial advice or an offer for securities. It highlights the risks associated with investing in Calix securities and notes that past performance is not indicative of future results. The company also outlines that the presentation contains forward-looking statements subject to change and advises potential investors to consider their own financial situation and seek appropriate advice.
Calix Ltd. has announced the issuance of 2,792,116 fully paid ordinary securities to be quoted on the Australian Securities Exchange (ASX) under the code CXL. This move follows a previously announced transaction and is a part of the company’s ongoing financial strategies. The announcement reflects Calix Ltd.’s efforts to enhance its market presence and operational capabilities, potentially impacting its stakeholders with increased liquidity and investment opportunities.
Calix Ltd. announced a change in the interest of its director, Sarah Ryan, as she acquired an additional 40,000 fully paid ordinary shares through a Share Purchase Plan. This acquisition increases her total holdings to 76,000 shares, reflecting confidence in the company’s growth prospects and potentially influencing investor sentiment positively.
Calix Limited announced a change in the shareholding of its director, Peter Dixon, who acquired 80,000 fully paid ordinary shares at $0.75 per share through a Share Purchase Plan, increasing his total holdings. This acquisition reflects potential confidence in the company’s growth prospects and could influence investor perception positively, as directors’ share purchases are often seen as a sign of optimism about the company’s future.
Calix Ltd. has announced a change in the director’s interest, with Helen Fisher acquiring an additional 40,000 ordinary shares through a Share Purchase Plan, increasing her total holdings to 56,120 shares. This acquisition reflects confidence in the company’s direction and future prospects, potentially influencing market perception and stakeholder interest.
Calix Limited announced a change in the director’s interest, revealing that Alison Deans acquired 40,000 additional fully paid ordinary shares through the company’s Share Purchase Plan at a price of $0.75 per share. This acquisition increases her total holdings to 140,000 shares, signifying an increased personal investment in the company and potentially reflecting confidence in its future performance.